Evaluation consists of the electrocardiograms for patients with cryptococcosis or ocd who both participated in premarketing studies revealed no differences between Diflucan and placebo in the emergence of clinically important ecg changes.
Evaluation consists of the electrocardiograms for patients with cryptococcosis or ocd who both participated in premarketing studies revealed no differences between Diflucan and placebo in the emergence of clinically important ecg changes.